BNT327, now in early-phase trials, is part of a class of drugs that could one day challenge Keytruda’s dominance. BioNTech ...

NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.

Novocure’s TTFields therapy combined with chemo improved overall survival by 16.2 months compared to 14.16 months with chemo ...

There's plenty of tech advancements as well, with the Global AI in Oncology Market growing at a rapid 35% CAGR, towards US$13.6 billion by 2032. Analysts at Spherical Insights project the global ...

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer ...

Final data demonstrate CM24 in combination with nivolumab and Nal-IRI/5FU/LV chemotherapy clear and consistent improvement across all efficacy ...

Epothilones (e.g., ixabepilone) induce microtubule polymerization through a mechanism that appears to be similar to that of paclitaxel, as epothilones compete with paclitaxel for binding to ...

The 3.0 utilizes the same basic concept, but adds a pressure boosting mechanism and an energy recovery system. As a result, it's said to be easier to pump than the original and faster at ...

1Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China. 2China-US (Henan) Hormel Cancer Institute, Zhengzhou, China. 3Tianjian Laboratory of Advanced ...

1Department of Biochemistry, School of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.